-
公开(公告)号:US5132425A
公开(公告)日:1992-07-21
申请号:US646314
申请日:1991-01-28
申请人: Kohshiro Sotoya , Uichiro Nishimoto , Hiroshi Abe
发明人: Kohshiro Sotoya , Uichiro Nishimoto , Hiroshi Abe
IPC分类号: A61K8/00 , A61K8/40 , A61Q5/00 , C07C215/40 , C07C215/42 , C07C217/42 , C07C245/04 , C07D295/088 , C11D1/62 , D06M13/02 , D06M13/322 , D06M13/46 , D06M13/467 , D06M13/47 , D06M13/477 , D06M101/12
CPC分类号: C07D295/088 , C07C215/40 , Y10S516/07
摘要: Novel quaternary ammonium compounds of formula (1) and (2): ##STR1## wherein R represents a straight or branched alkylene group containing from 2 to 24 carbon atoms, an alicyclic alkylene group, an aralkylene group or a group of the formula --CH.sub.2 CH.sub.2 O).sub.p (CH.sub.2 CH.sub.2).sub.q (in which p and q each represents a positive integer), R' represents a straight or branched alkyl group containing from 1 to 24 carbon atoms, an alkenyl group or an aralkyl group, R" represents an alkyl group containing 1 to 5 carbon atoms or an aralkyl group, X.sup.- represents an anionic group and n represents a positive integer of from 2 to 50 are disclosed. The quaternary ammonium compounds are useful as surfactants capable of serving as softening agents and antistatic agents for fabrics, hair and the like.
-
公开(公告)号:US4873262A
公开(公告)日:1989-10-10
申请号:US132372
申请日:1987-12-15
申请人: Bodo Junge , Bernd Richter , Thomas Glaser , Jorg Traber , George S. Allen
发明人: Bodo Junge , Bernd Richter , Thomas Glaser , Jorg Traber , George S. Allen
IPC分类号: C07D295/04 , A61K31/135 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/195 , A61K31/235 , A61K31/24 , A61K31/255 , A61K31/27 , A61K31/275 , A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/41 , A61K31/425 , A61K31/428 , A61K31/445 , A61K31/495 , A61K31/54 , A61P1/00 , A61P9/00 , A61P25/00 , A61P43/00 , C07C211/42 , C07C211/60 , C07C215/42 , C07C215/44 , C07C217/74 , C07C223/04 , C07C225/20 , C07C229/50 , C07C233/00 , C07C233/18 , C07C233/36 , C07C233/43 , C07C235/06 , C07C237/06 , C07C237/20 , C07C237/48 , C07C255/58 , C07C271/16 , C07C271/20 , C07C275/10 , C07C275/22 , C07C275/40 , C07C311/00 , C07C311/02 , C07C311/04 , C07C311/05 , C07C311/08 , C07C311/13 , C07C311/15 , C07C311/17 , C07C311/18 , C07C311/24 , C07C311/35 , C07D209/44 , C07D209/48 , C07D211/88 , C07D221/20 , C07D275/04 , C07D275/06 , C07D279/02 , C07D307/58 , C07D333/26 , C07D471/10 , C07D521/00
CPC分类号: C07D275/04 , C07C255/00
摘要: New 8-substituted 2-aminotetralins can be prepared from the corresponding aminotetralins or tetralones. They can be used in medicaments.
摘要翻译: 新的8-取代的2-氨基鸟嘌呤可以由相应的氨基四氢萘酮或四氢萘酮制备。 它们可用于药物。
-
公开(公告)号:US4820873A
公开(公告)日:1989-04-11
申请号:US102275
申请日:1987-09-28
申请人: Kenneth W. Bair
发明人: Kenneth W. Bair
IPC分类号: C07D295/08 , A61K31/045 , A61K31/135 , A61K31/255 , A61K31/275 , A61K31/415 , A61K31/42 , A61K31/535 , A61K31/5375 , A61P31/00 , A61P35/00 , B01J27/135 , C07B61/00 , C07C29/147 , C07C33/46 , C07C63/44 , C07C63/70 , C07C66/02 , C07C67/00 , C07C69/76 , C07C205/15 , C07C213/00 , C07C213/02 , C07C215/06 , C07C215/08 , C07C215/10 , C07C215/20 , C07C215/28 , C07C215/38 , C07C215/42 , C07C215/44 , C07C217/48 , C07C217/58 , C07C253/00 , C07C255/56 , C07C255/58 , C07C313/00 , C07C315/04 , C07C317/32 , C07C317/36 , C07C319/20 , C07C323/32 , C07C323/36 , C07C323/38 , C07D213/02 , C07D233/61 , C07D263/52 , C07D263/62 , C07D263/64 , C07D295/10 , C07D295/12 , C07D295/135 , C07D309/12 , C07D317/32 , C07D319/06 , C07D498/04 , C07D521/00 , C07J63/00 , C07C87/28
CPC分类号: A61K31/045 , C07C205/15 , C07C215/10 , C07C215/28 , C07C215/42 , C07C217/48 , C07C217/58 , C07C255/58 , C07C317/32 , C07C323/32 , C07D231/12 , C07D233/56 , C07D249/08 , C07D263/52 , C07D263/64 , C07D295/135 , C07D309/12 , C07D319/06 , C07J63/008 , C07C2101/14 , C07C2103/24 , C07C2103/26 , C07C2103/40 , C07C2103/42 , C07C2103/48 , C07C2103/50 , Y10S514/908
摘要: The present invention relates to compounds of formula (I)ArCH.sub.2 R.sup.1 (I)or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a pyrene or substituted pyrene ring system; R.sup.1 contains not more than eight carbon carbon atoms and is a group ##STR1## wherein m is 0 or 1; R.sup.5 is hydrogen;R.sup.6 and R.sup.7 are the same or different and each is hydrogen or C.sub.1-3 alkyl optionally substituted by hydroxy;R.sup.8 and R.sup.9 are the same or different and each is hydrogen or C.sub.1-3 alkyl; ##STR2## is a five- or six-membered saturated carbocyclic ring; R.sup.10 is hydrogen, methyl or hydroxymethyl;R.sup.11, R.sup.12 and R.sup.13 are the same or different and each is hydrogen or methyl;R.sup.14 is hydrogen, methyl, hydroxy, or hydroxymethyl.
-
公开(公告)号:US4530800A
公开(公告)日:1985-07-23
申请号:US499813
申请日:1983-06-01
申请人: Kenneth W. Bair
发明人: Kenneth W. Bair
IPC分类号: C07D295/08 , A61K31/045 , A61K31/135 , A61K31/255 , A61K31/275 , A61K31/415 , A61K31/42 , A61K31/535 , A61K31/5375 , A61P31/00 , A61P35/00 , B01J27/135 , C07B61/00 , C07C29/147 , C07C33/46 , C07C63/44 , C07C63/70 , C07C66/02 , C07C67/00 , C07C69/76 , C07C205/15 , C07C213/00 , C07C213/02 , C07C215/06 , C07C215/08 , C07C215/10 , C07C215/20 , C07C215/28 , C07C215/38 , C07C215/42 , C07C215/44 , C07C217/48 , C07C217/58 , C07C253/00 , C07C255/56 , C07C255/58 , C07C313/00 , C07C315/04 , C07C317/32 , C07C317/36 , C07C319/20 , C07C323/32 , C07C323/36 , C07C323/38 , C07D213/02 , C07D233/61 , C07D263/52 , C07D263/62 , C07D263/64 , C07D295/10 , C07D295/12 , C07D295/135 , C07D309/12 , C07D317/32 , C07D319/06 , C07D498/04 , C07D521/00 , C07J63/00 , C07C67/02 , C07C87/455
CPC分类号: A61K31/045 , C07C205/15 , C07C215/10 , C07C215/28 , C07C215/42 , C07C217/48 , C07C217/58 , C07C255/58 , C07C317/32 , C07C323/32 , C07D231/12 , C07D233/56 , C07D249/08 , C07D263/52 , C07D263/64 , C07D295/135 , C07D309/12 , C07D319/06 , C07J63/008 , C07C2101/14 , C07C2103/24 , C07C2103/26 , C07C2103/40 , C07C2103/42 , C07C2103/48 , C07C2103/50 , Y10S514/908
摘要: The present invention relates to compounds of formula (I) ##STR1## wherein Ar is a perylene or substituted perylene ring system;R.sup.1 is a C.sub.1-3 alkylene moiety;R.sup.2 is hydrogen or a C.sub.1-6 alkyl group;R.sup.3 is hydroxyl C.sub.1-6 alkyl group;R.sup.4 and R.sup.5 are the same or different and are hydrogen, C.sub.1-6 alkyl or hydroxy C.sub.1-6 alkyl, esters thereof derived from condensation of carboxylic acids and hydroxyl groups of R.sup.3, R.sup.4, and R.sup.5 ;Acid addition salts thereof, which have been found useful for the treatment of tumors in mammals.
摘要翻译: 本发明涉及式(I)化合物:其中Ar是苝或取代的二萘嵌苯环体系; R1是C1-3亚烷基部分; R2是氢或C1-6烷基; R3是羟基C1-6烷基; R4和R5相同或不同,为氢,C1-6烷基或羟基C1-6烷基,其衍生自羧酸和R3,R4和R5的羟基的缩合的酯; 已经发现其酸加成盐可用于治疗哺乳动物的肿瘤。
-
公开(公告)号:US4490555A
公开(公告)日:1984-12-25
申请号:US360090
申请日:1982-03-19
申请人: John C. Sih
发明人: John C. Sih
IPC分类号: C07C69/738 , C07C27/00 , C07C31/44 , C07C33/40 , C07C35/52 , C07C41/00 , C07C43/23 , C07C51/00 , C07C59/115 , C07C59/56 , C07C59/58 , C07C67/00 , C07C69/67 , C07C69/732 , C07C201/00 , C07C205/34 , C07C205/45 , C07C205/57 , C07C213/00 , C07C215/26 , C07C215/42 , C07C217/44 , C07C217/48 , C07C233/06 , C07C233/11 , C07C233/15 , C07C233/25 , C07C233/33 , C07C235/14 , C07C235/26 , C07C235/30 , C07C235/36 , C07C237/20 , C07C237/22 , C07C239/00 , C07C253/00 , C07C255/31 , C07C255/47 , C07C275/04 , C07C281/14 , C07C301/00 , C07C311/00 , C07C311/47 , C07C405/00 , C07D309/12 , C07F9/38 , C07F9/40 , C07C177/00 , C07C57/26
CPC分类号: C07C405/0083 , Y02P20/55
摘要: Novel compounds of the following general formula: ##STR1##
摘要翻译: 以下通式的新型化合物:
-
公开(公告)号:US4487961A
公开(公告)日:1984-12-11
申请号:US349145
申请日:1982-02-16
申请人: Paul A. Aristoff
发明人: Paul A. Aristoff
IPC分类号: C07C69/67 , A61K31/557 , A61P7/02 , A61P11/00 , A61P35/00 , A61P35/02 , C07C27/00 , C07C31/27 , C07C31/44 , C07C33/05 , C07C33/44 , C07C35/31 , C07C35/52 , C07C45/00 , C07C47/38 , C07C51/00 , C07C59/01 , C07C59/147 , C07C59/42 , C07C59/46 , C07C59/74 , C07C67/00 , C07C69/73 , C07C205/45 , C07C213/00 , C07C215/26 , C07C215/42 , C07C231/00 , C07C233/08 , C07C233/10 , C07C233/11 , C07C233/65 , C07C233/67 , C07C233/70 , C07C233/72 , C07C233/73 , C07C233/76 , C07C235/06 , C07C235/16 , C07C235/26 , C07C235/30 , C07C235/32 , C07C235/72 , C07C235/74 , C07C235/76 , C07C235/78 , C07C237/20 , C07C239/00 , C07C253/00 , C07C255/31 , C07C255/47 , C07C275/04 , C07C281/14 , C07C301/00 , C07C311/50 , C07C405/00 , C07D309/12 , C07F7/18 , C07F9/38 , C07F9/40 , C07C177/00 , C07C57/26
CPC分类号: C07C255/00 , C07C405/0083 , C07C59/01 , C07F7/1852
摘要: Novel compounds of the following general formula: ##STR1##
-
公开(公告)号:US3751420A
公开(公告)日:1973-08-07
申请号:US3751420D
申请日:1971-04-01
申请人: SQUIBB & SONS INC
IPC分类号: C07D295/08 , C07C35/23 , C07C35/34 , C07C35/36 , C07C41/00 , C07C43/18 , C07C67/00 , C07C69/013 , C07C69/753 , C07C209/00 , C07C209/28 , C07C209/36 , C07C209/40 , C07C211/19 , C07C211/42 , C07C213/00 , C07C215/42 , C07C217/52 , C07C219/24 , C07C225/18 , C07C225/20 , C07C231/00 , C07C231/10 , C07C231/12 , C07C233/18 , C07C233/23 , C07C233/28 , C07C239/00 , C07C239/12 , C07C271/06 , C07C301/00 , C07C303/28 , C07C303/40 , C07C311/00 , C07D215/06 , C07D217/04 , C07D243/08 , C07D245/02 , C07D295/096 , C07D303/36 , C07D317/72 , C07D29/16
CPC分类号: C07D295/096 , C07C35/23 , C07C35/34 , C07C35/36 , C07D303/36 , C07D317/72 , Y02P20/55
摘要: MONOOLMONOENE AMINES ARE PROVIDED HAVING THE STRUCTURE
CH2
(-R2)(-R3)(-X-Y)
WHICH ARE USEFUL AS ANALGETIC MUSCLE RELAXANTS.-
68.
公开(公告)号:US20230364035A1
公开(公告)日:2023-11-16
申请号:US18133060
申请日:2023-04-11
申请人: ATROGI AB
发明人: Benjamin Pelcman , Tore Bengtsson
IPC分类号: A61K31/137 , A61P3/10 , A61K31/167 , C07C215/34 , C07C215/42 , C07C215/68 , C07C233/43
CPC分类号: A61K31/137 , A61P3/10 , A61K31/167 , C07C215/34 , C07C215/42 , C07C215/68 , C07C233/43
摘要: There is herein provided a compound of formula (I).
-
公开(公告)号:US20220331346A1
公开(公告)日:2022-10-20
申请号:US17307138
申请日:2021-05-04
发明人: Alaric J. DYCKMAN , T.G. Murali Dhar , Hai-Yun Xiao , John L. Gilmore , Michael G. Yang , Zili Xiao , David Marcoux
IPC分类号: A61K31/695 , C07F7/08 , A61K31/135 , C07D215/14 , C07D241/04 , C07C323/29 , C07C251/38 , C07C251/42 , C07C251/44 , C07D209/46 , C07D213/38 , C07C275/26 , C07C217/74 , C07C323/25 , C07C235/46 , C07F9/54 , C07F9/572 , C07F9/09 , C07C215/42 , C07C217/52 , C07C217/58 , C07C219/24 , C07C233/41 , C07C233/65 , C07C251/50 , C07C251/52 , C07C251/54 , C07C271/34 , C07C317/28 , C07C317/32 , C07C321/16 , C07C321/22 , C07C321/28 , C07D213/32 , C07D213/69 , C07D213/70 , C07D215/12 , C07D217/24 , C07D231/12 , C07D231/20 , C07D239/26 , C07D241/12 , C07D277/24 , C07D305/08 , C07D309/06 , C07D309/12 , C07D311/58 , C07D311/76 , C07D319/20 , C07D333/16 , C07F9/117 , C07F9/62 , C07F9/6503 , C07F9/6509 , C07F9/655 , C07F9/6553 , A61K31/137 , A61K31/15 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/222 , A61K31/24 , A61K31/27 , A61K31/337 , A61K31/351 , A61K31/352 , A61K31/381 , A61K31/415 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61K31/4965 , A61K31/505 , A61K31/661
摘要: Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V): and/or a salt thereof, wherein R1 is —OH or —OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
-
公开(公告)号:US20200281952A1
公开(公告)日:2020-09-10
申请号:US16879824
申请日:2020-05-21
发明人: Alaric J. Dyckman , T.G. Murali Dhar , Hai-Yun Xiao , John L. Gilmore , Michael G. Yang , Zili Xiao , David Marcoux
IPC分类号: A61K31/695 , C07F7/08 , A61K31/135 , C07D215/14 , C07D241/04 , C07C323/29 , C07C251/38 , C07C251/42 , C07C251/44 , C07D209/46 , C07D213/38 , C07C275/26 , C07C217/74 , C07C323/25 , C07C235/46 , C07F9/54 , C07F9/572 , C07F9/09 , C07C215/42 , C07C217/52 , C07C217/58 , C07C219/24 , C07C233/41 , C07C233/65 , C07C251/50 , C07C251/52 , C07C251/54 , C07C271/34 , C07C317/28 , C07C317/32 , C07C321/16 , C07C321/22 , C07C321/28 , C07D213/32 , C07D213/69 , C07D213/70 , C07D215/12 , C07D217/24 , C07D231/12 , C07D231/20 , C07D239/26 , C07D241/12 , C07D277/24 , C07D305/08 , C07D309/06 , C07D309/12 , C07D311/58 , C07D311/76 , C07D319/20 , C07D333/16 , C07F9/117 , C07F9/62 , C07F9/6503 , C07F9/6509 , C07F9/655 , C07F9/6553 , A61K31/137 , A61K31/15 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/222 , A61K31/24 , A61K31/27 , A61K31/337 , A61K31/351 , A61K31/352 , A61K31/381 , A61K31/415 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61K31/4965 , A61K31/505 , A61K31/661
摘要: Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V): and/or a salt thereof, wherein R1 is —OH or —OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
-
-
-
-
-
-
-
-
-